Improved metrics for Huntington's disease trials

Professor Sarah Tabrizi (UCL Institute of Neurology) says we're in a 'new era' of Huntington's disease clinical trials, and discusses the drug trial with Ionis Pharmaceuticals that she finalised this year. Read: Nature, More: Nature (2)